MetaADEDB 2.0 @ LMMD
Latanoprost
(GGXICVAJURFBLW-CEYXHVGTSA-N)
Structure
SMILES
O[C@@H](CCc1ccccc1)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)OC(C)C)O
Type(s)
Approved; Investigational
ATC code(s)
S01EE01
Molecular Formula:
C26H40O5
Molecular Weight:
432.593
Log P:
4.1864
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
3
TPSA:
86.99
CAS Number(s):
130209-82-4; 155551-81-8
Synonym(s)
1.
Latanoprost
2.
PHXA41
3.
PhXA34
4.
Xalatan
External Link(s)
MeSHD000077338
PubChem Compound5311221
BindingDB50240648
ChEBI6384
CHEMBLCHEMBL1051
DrugBankDB00654
DrugCentral1551
IUPHAR/BPS Guide to PHARMACOLOGY1961
KEGGdr:D00356
Therapeutic Target DatabaseD0C6NM
ZINC12468792
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Eye irritationFAERS: 730
Canada Vigilance: 12
Canada Vigilance
SIDER
US FAERS
2Drug ineffectiveFAERS: 522
Canada Vigilance: 25
Canada Vigilance
US FAERS
3CataractFAERS: 478
Canada Vigilance: 9
Canada Vigilance
OFFSIDES
US FAERS
4Eye painFAERS: 412
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
SIDER
US FAERS
5GlaucomaFAERS: 260
Canada Vigilance: 3

View details

CTD
OFFSIDES
Canada Vigilance
US FAERS
6Visual ImpairmentFAERS: 213
Canada Vigilance: 6
Canada Vigilance
US FAERS
7Product quality issueFAERS: 193
Canada Vigilance: 1
Canada Vigilance
US FAERS
8HeadacheFAERS: 163
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
9Incorrect dose administeredFAERS: 130
Canada Vigilance: 1
Canada Vigilance
US FAERS
10MalaiseFAERS: 122US FAERS
11BlindnessFAERS: 121
Canada Vigilance: 1
Canada Vigilance
US FAERS
12HypersensitivityFAERS: 112
Canada Vigilance: 5
Canada Vigilance
US FAERS
13DizzinessFAERS: 101OFFSIDES
SIDER
US FAERS
14Foreign body sensation in eyesFAERS: 93US FAERS
15Cataract operationFAERS: 81
Canada Vigilance: 8
Canada Vigilance
OFFSIDES
US FAERS
16Product substitution issueFAERS: 81
Canada Vigilance: 14
Canada Vigilance
US FAERS
17Cerebrovascular accidentFAERS: 79US FAERS
18PainFAERS: 69
Canada Vigilance: 3
17102001CTD
SIDER
Canada Vigilance
US FAERS
19PruritusFAERS: 6717102001CTD
SIDER
US FAERS
20Product container issueFAERS: 54
Canada Vigilance: 1
Canada Vigilance
US FAERS
21Drug dose omissionFAERS: 51US FAERS
22Growth of eyelashesFAERS: 51US FAERS
23Diabetes MellitusFAERS: 50
Canada Vigilance: 1
Canada Vigilance
US FAERS
24NasopharyngitisFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
25Intraocular pressure test abnormalFAERS: 48
Canada Vigilance: 2
Canada Vigilance
US FAERS
26ArthralgiaFAERS: 46SIDER
US FAERS
27Eye InfectionFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
28FatigueFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Myocardial InfarctionFAERS: 44US FAERS
30NauseaFAERS: 44OFFSIDES
US FAERS
31ErythemaFAERS: 43
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
32Macular degenerationFAERS: 43
Canada Vigilance: 2
Canada Vigilance
US FAERS
33Feeling abnormalFAERS: 42US FAERS
34Product dropper issueFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
35DeafnessFAERS: 39
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
36Incorrect product storageFAERS: 39US FAERS
37Memory impairmentFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
38MyalgiaFAERS: 38US FAERS
39Ocular discomfortFAERS: 38
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
40AsthmaFAERS: 37OFFSIDES
SIDER
US FAERS
41InfluenzaFAERS: 37US FAERS
42PalpitationsFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
43Burning sensationFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Drug administration errorFAERS: 35US FAERS
45PhotophobiaFAERS: 35
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
46Product use issueFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
47AnxietyFAERS: 34US FAERS
48ArthritisFAERS: 34
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
49VertigoFAERS: 34US FAERS
50AstheniaFAERS: 33US FAERS
51Pharmaceutical product complaintFAERS: 33US FAERS
52AsthenopiaFAERS: 32OFFSIDES
US FAERS
53ConjunctivitisFAERS: 32
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
54Eye inflammationFAERS: 32US FAERS
55ArthropathyFAERS: 31US FAERS
56Circumstance or information capable of leading to medication errorFAERS: 30US FAERS
57Product storage errorFAERS: 29US FAERS
58Chest PainFAERS: 28SIDER
US FAERS
59NervousnessFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
60DiplopiaFAERS: 27
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
61No adverse eventFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
62Expired drug administeredFAERS: 26OFFSIDES
US FAERS
63Poor quality drug administeredFAERS: 25OFFSIDES
US FAERS
64Chest discomfortFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
65DiscomfortFAERS: 24SIDER
US FAERS
66Medication ErrorFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
67OverdoseFAERS: 22US FAERS
68Product packaging quantity issueFAERS: 22US FAERS
69Reaction to preservativesFAERS: 22US FAERS
70Retinal DetachmentFAERS: 22SIDER
US FAERS
71TremorFAERS: 22US FAERS
72Dark circles under eyesFAERS: 21US FAERS
73PneumoniaFAERS: 21US FAERS
74Accidental exposure to productFAERS: 20US FAERS
75Incorrect storage of drugFAERS: 20US FAERS
76Product packaging issueFAERS: 20US FAERS
77Weight decreasedFAERS: 20US FAERS
78EpistaxisFAERS: 19US FAERS
79Eyelids pruritusFAERS: 19
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
80SomnolenceFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
81TachycardiaFAERS: 19US FAERS
82Back PainFAERS: 18SIDER
US FAERS
83Blood cholesterol increasedFAERS: 18US FAERS
84BronchitisFAERS: 18SIDER
US FAERS
85Intraocular pressure fluctuationFAERS: 18US FAERS
86Oropharyngeal painFAERS: 18US FAERS
87Drug effect incompleteFAERS: 17US FAERS
88Dry skinFAERS: 17US FAERS
89DysphoniaFAERS: 17OFFSIDES
US FAERS
90Inappropriate schedule of drug administrationFAERS: 17US FAERS
91Intentional product misuseFAERS: 17US FAERS
92Abdominal discomfortFAERS: 16US FAERS
93Accidental overdoseFAERS: 16US FAERS
94Angina PectorisFAERS: 16SIDER
US FAERS
95Eye BurnsFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
96Eye laser surgeryFAERS: 16
Canada Vigilance: 8
Canada Vigilance
US FAERS
97Eyelid irritationFAERS: 16US FAERS
98Instillation site painFAERS: 16US FAERS
99Unevaluable eventFAERS: 16US FAERS
100Eyelid margin crustingFAERS: 15US FAERS
101Glaucoma surgeryFAERS: 15OFFSIDES
US FAERS
102Product formulation issueFAERS: 15US FAERS
103Throat irritationFAERS: 15US FAERS
104ThrombosisFAERS: 15US FAERS
105UrticariaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
106VomitingFAERS: 15US FAERS
107treatment failureFAERS: 15US FAERS
108AbasiaFAERS: 14US FAERS
109Disease ProgressionFAERS: 14US FAERS
110Eyelash thickeningFAERS: 14US FAERS
111SwellingFAERS: 14US FAERS
112SyncopeFAERS: 14US FAERS
113TinnitusFAERS: 14
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
114Atrial FibrillationFAERS: 13US FAERS
115BedriddenFAERS: 13US FAERS
116Depressed moodFAERS: 13US FAERS
117InfarctionFAERS: 13US FAERS
118Iris hyperpigmentationFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
119Joint injuryFAERS: 13US FAERS
120KeratitisFAERS: 13SIDER
US FAERS
121Product administration errorFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
122AlopeciaFAERS: 12US FAERS
123MyopiaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Ocular vascular disorderFAERS: 12US FAERS
125Product use complaintFAERS: 12US FAERS
126AmnesiaFAERS: 11US FAERS
127BradycardiaFAERS: 11US FAERS
128DementiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
129DysgeusiaFAERS: 11US FAERS
130HypothyroidismFAERS: 11US FAERS
131InfectionFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
132InflammationFAERS: 11SIDER
US FAERS
133StressFAERS: 11US FAERS
134UveitisFAERS: 1119403113CTD
SIDER
US FAERS
135Visual disturbanceFAERS: 11US FAERS
136Vitreous floatersFAERS: 11US FAERS
137BlepharitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
138Cardiac ArrestFAERS: 10US FAERS
139Erectile dysfunctionFAERS: 10US FAERS
140Eye allergyFAERS: 10US FAERS
141Nasal discomfortFAERS: 10US FAERS
142Productive CoughFAERS: 10US FAERS
143Reaction to drug excipientsFAERS: 10US FAERS
144Superficial injury of eyeFAERS: 10US FAERS
145Abdominal PainFAERS: 9US FAERS
146Blood creatine phosphokinase increasedFAERS: 9US FAERS
147Choroidal DetachmentFAERS: 9US FAERS
148Disease recurrenceFAERS: 9US FAERS
149General physical health deteriorationFAERS: 9US FAERS
150HypotensionFAERS: 9US FAERS
151IridocyclitisFAERS: 9US FAERS
152MetamorphopsiaFAERS: 9US FAERS
153Ocular HypertensionFAERS: 9
Canada Vigilance: 1

View details

CTD
Canada Vigilance
US FAERS
154Product container seal issueFAERS: 9US FAERS
155AnosmiaFAERS: 8US FAERS
156Back disorderFAERS: 8US FAERS
157HerniaFAERS: 8US FAERS
158Limb injuryFAERS: 8US FAERS
159Neck PainFAERS: 8US FAERS
160Poor quality product administeredFAERS: 8US FAERS
161Urinary tract infectionFAERS: 8SIDER
US FAERS
162WheezingFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
163nervous system disorderFAERS: 8SIDER
US FAERS
164Cerebral InfarctionFAERS: 7US FAERS
165CyanopsiaFAERS: 7US FAERS
166Expired product administeredFAERS: 7US FAERS
167Eyelid exfoliationFAERS: 7US FAERS
168HemiplegiaFAERS: 7US FAERS
169HordeolumFAERS: 7US FAERS
170Lip swellingFAERS: 7US FAERS
171Musculoskeletal PainFAERS: 7US FAERS
172Musculoskeletal stiffnessFAERS: 7US FAERS
173OsteoporosisFAERS: 7US FAERS
174Post procedural complicationFAERS: 7US FAERS
175Respiratory FailureFAERS: 7US FAERS
176SinusitisFAERS: 7US FAERS
177Upper-airway cough syndromeFAERS: 7US FAERS
178Wrong drug administeredFAERS: 7US FAERS
179AcromegalyFAERS: 6US FAERS
180Choking sensationFAERS: 6US FAERS
181ChromaturiaFAERS: 6US FAERS
182Corneal OpacityFAERS: 6US FAERS
183Drug ToleranceFAERS: 6US FAERS
184Drug exposure during pregnancyFAERS: 6US FAERS
185Gamma-Glutamyltransferase IncreasedFAERS: 6US FAERS
186HypertrichosisFAERS: 6
Canada Vigilance: 1
17539800
18166407
CTD
Canada Vigilance
US FAERS
187IritisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
188LabyrinthitisFAERS: 6US FAERS
189Mental impairmentFAERS: 6US FAERS
190Muscle tightnessFAERS: 6US FAERS
191Musculoskeletal chest painFAERS: 6OFFSIDES
US FAERS
192MydriasisFAERS: 6US FAERS
193Ocular surface diseaseFAERS: 6US FAERS
194Product contaminationFAERS: 6US FAERS
195Product dose omissionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
196Product label issueFAERS: 6US FAERS
197Punctate keratitisFAERS: 6US FAERS
198Retinal Vein OcclusionFAERS: 6US FAERS
199Rheumatoid ArthritisFAERS: 6US FAERS
200Wrong technique in product usage processFAERS: 6US FAERS
201AngioedemaFAERS: 5US FAERS
202BlepharospasmFAERS: 5US FAERS
203Blood glucose increasedFAERS: 5US FAERS
204Blood sodium decreasedFAERS: 5US FAERS
205ColitisFAERS: 5US FAERS
206Drug dispensing errorFAERS: 5US FAERS
207Ear discomfortFAERS: 5US FAERS
208Emotional disorderFAERS: 5US FAERS
209Increased upper airway secretionFAERS: 5OFFSIDES
US FAERS
210Middle insomniaFAERS: 5US FAERS
211Pulmonary EmbolismFAERS: 5US FAERS
212Respiratory tract congestionFAERS: 5US FAERS
213ScleritisFAERS: 5US FAERS
214Senile dementiaFAERS: 5US FAERS
215UlcerFAERS: 5US FAERS
216Activities of daily living impairedFAERS: 4OFFSIDES
US FAERS
217AgeusiaFAERS: 4OFFSIDES
US FAERS
218AneurysmFAERS: 4US FAERS
219Application site reactionFAERS: 4US FAERS
220Atrioventricular BlockFAERS: 4OFFSIDES
US FAERS
221Blood urine presentFAERS: 4US FAERS
222BronchospasmFAERS: 4US FAERS
223CholelithiasisFAERS: 4US FAERS
224DisabilityFAERS: 4US FAERS
225Drug ineffective for unapproved indicationFAERS: 4US FAERS
226DysgraphiaFAERS: 4US FAERS
227DysuriaFAERS: 4US FAERS
228EpilepsyFAERS: 4US FAERS
229Extra dose administeredFAERS: 4US FAERS
230Eye operation complicationFAERS: 4US FAERS
231FlushingFAERS: 4US FAERS
232FractureFAERS: 4US FAERS
233GastritisFAERS: 4US FAERS
234HypokinesiaFAERS: 4US FAERS
235Intraocular pressure testFAERS: 4OFFSIDES
US FAERS
236Liquid product physical issueFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
237Medication residue presentFAERS: 4US FAERS
238Muscle RigidityFAERS: 4US FAERS
239Musculoskeletal discomfortFAERS: 4SIDER
US FAERS
240NephrolithiasisFAERS: 4US FAERS
241Peritonitis viralFAERS: 4US FAERS
242Physical product label issueFAERS: 4US FAERS
243PolyneuropathyFAERS: 4US FAERS
244Product complaintFAERS: 4
Canada Vigilance: 5
Canada Vigilance
US FAERS
245Product depositFAERS: 4US FAERS
246Product dispensing errorFAERS: 4US FAERS
247Product package associated injuryFAERS: 4US FAERS
248Product physical issueFAERS: 4US FAERS
249Product tamperingFAERS: 4US FAERS
250Product use in unapproved indicationFAERS: 4US FAERS
251PterygiumFAERS: 4US FAERS
252RestlessnessFAERS: 4US FAERS
253Secretion dischargeFAERS: 4US FAERS
254Sense of oppressionFAERS: 4US FAERS
255Skin PapillomaFAERS: 4US FAERS
256Therapeutic response unexpectedFAERS: 4US FAERS
257Throat cancerFAERS: 4US FAERS
258UnderweightFAERS: 4US FAERS
259Uterine CancerFAERS: 4US FAERS
260Vitreous DetachmentFAERS: 4US FAERS
261Vitreous adhesionsFAERS: 4US FAERS
262Wrong technique in drug usage processFAERS: 4US FAERS
263YawningFAERS: 4US FAERS
264AcneFAERS: 3US FAERS
265Angle Closure GlaucomaFAERS: 3US FAERS
266Ankle FractureFAERS: 3US FAERS
267AphasiaFAERS: 3US FAERS
268AphoniaFAERS: 3US FAERS
269Application site painFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
270AstigmatismFAERS: 3US FAERS
271Basal cell carcinomaFAERS: 3US FAERS
272Blood catecholamines increasedFAERS: 3US FAERS
273Blood cholesterol abnormalFAERS: 3US FAERS
274Blood potassium decreasedFAERS: 3OFFSIDES
US FAERS
275Cardiac HypertrophyFAERS: 3OFFSIDES
US FAERS
276Carpal Tunnel SyndromeFAERS: 3US FAERS
277Conjunctival irritationFAERS: 3US FAERS
278Conjunctival primary acquired melanosisFAERS: 3US FAERS
279Corneal ScarFAERS: 3US FAERS
280Corneal epithelium disorderFAERS: 3US FAERS
281CystFAERS: 3US FAERS
282DehydrationFAERS: 3US FAERS
283Dental cariesFAERS: 3OFFSIDES
US FAERS
284DermatitisFAERS: 3SIDER
US FAERS
285Diabetic RetinopathyFAERS: 3OFFSIDES
SIDER
US FAERS
286DisorientationFAERS: 3US FAERS
287DiverticulitisFAERS: 3US FAERS
288Drug effect delayedFAERS: 3US FAERS
289Drug prescribing errorFAERS: 3US FAERS
290Drug toxicityFAERS: 3OFFSIDES
US FAERS
291DyspepsiaFAERS: 3US FAERS
292EczemaFAERS: 3SIDER
US FAERS
293Excessive eye blinkingFAERS: 3US FAERS
294Eyelid painFAERS: 3US FAERS
295Eyelid skin drynessFAERS: 3US FAERS
296Feeling ColdFAERS: 3US FAERS
297Gait inabilityFAERS: 3US FAERS
298HemicephalalgiaFAERS: 3US FAERS
299HirsutismFAERS: 3US FAERS
300Instillation site erythemaFAERS: 3US FAERS
301Instillation site irritationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
302Intentional product use issueFAERS: 3US FAERS
303Intestinal ObstructionFAERS: 3US FAERS
304Joint swellingFAERS: 3US FAERS
305LethargyFAERS: 3US FAERS
306Limb discomfortFAERS: 3US FAERS
307Multiple allergiesFAERS: 3OFFSIDES
US FAERS
308Nerve injuryFAERS: 3US FAERS
309Night sweatsFAERS: 3US FAERS
310No adverse effectFAERS: 3US FAERS
311Oropharyngeal discomfortFAERS: 3US FAERS
312Periorbital disorderFAERS: 3US FAERS
313Peripheral swellingFAERS: 3US FAERS
314PharyngitisFAERS: 3US FAERS
315Pharyngolaryngeal PainFAERS: 3US FAERS
316PregnancyFAERS: 3US FAERS
317Product closure removal difficultFAERS: 3US FAERS
318Product physical consistency issueFAERS: 3US FAERS
319ProteinuriaFAERS: 3US FAERS
320Psychiatric symptomFAERS: 3US FAERS
321Pulmonary FibrosisFAERS: 3US FAERS
322Purulent dischargeFAERS: 3US FAERS
323RetinitisFAERS: 3US FAERS
324RhinalgiaFAERS: 3US FAERS
325RhinitisFAERS: 3US FAERS
326SepsisFAERS: 3US FAERS
327Sjogren's SyndromeFAERS: 3US FAERS
328SneezingFAERS: 3US FAERS
329StrabismusFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
330Supraventricular tachycardiaFAERS: 3US FAERS
331ToothacheFAERS: 3US FAERS
332Transmission of an infectious agent via a medicinal productFAERS: 3US FAERS
333VaricophlebitisFAERS: 3US FAERS
334Venous ThrombosisFAERS: 3US FAERS
335Accidental drug intake by childFAERS: 2US FAERS
336Accidental exposureFAERS: 2US FAERS
337AgitationFAERS: 2US FAERS
338Allergic reaction to excipientFAERS: 2US FAERS
339Alopecia AreataFAERS: 2US FAERS
340Anaphylactic shockFAERS: 2US FAERS
341AngerFAERS: 2US FAERS
342Animal biteFAERS: 2US FAERS
343AniridiaFAERS: 2US FAERS
344Anorectal discomfortFAERS: 2US FAERS
345Application site irritationFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
346ArteriosclerosisFAERS: 2US FAERS
347Auricular swellingFAERS: 2US FAERS
348Benign Prostatic HyperplasiaFAERS: 2OFFSIDES
US FAERS
349Blood glucose abnormalFAERS: 2US FAERS
350Blood pressure fluctuationFAERS: 2US FAERS
351Blood testosterone increasedFAERS: 2US FAERS
352Bone painFAERS: 2US FAERS
353BronchiectasisFAERS: 2US FAERS
354BursitisFAERS: 2US FAERS
355CandidiasisFAERS: 2US FAERS
356Cardiac stress test abnormalFAERS: 2US FAERS
357CardiomegalyFAERS: 2US FAERS
358Cardiovascular insufficiencyFAERS: 2US FAERS
359Carotid artery occlusionFAERS: 2US FAERS
360Cerumen removalFAERS: 2US FAERS
361Cervix carcinomaFAERS: 2US FAERS
362ChokingFAERS: 2US FAERS
363ChorioretinitisFAERS: 2US FAERS
364ChromatopsiaFAERS: 2US FAERS
365ClumsinessFAERS: 2US FAERS
366ConstipationFAERS: 2US FAERS
367Contact lens intoleranceFAERS: 2US FAERS
368Corneal UlcerFAERS: 2US FAERS
369Corneal decompensationFAERS: 2US FAERS
370Corneal degenerationFAERS: 2US FAERS
371Corneal dystrophyFAERS: 2US FAERS
372Corneal epithelium defectFAERS: 2US FAERS
373Corneal erosionFAERS: 2US FAERS
374Corneal lesionFAERS: 2
Canada Vigilance: 4
Canada Vigilance
US FAERS
375Coronary Artery DiseaseFAERS: 2US FAERS
376CystitisFAERS: 2US FAERS
377Deafness NeurosensoryFAERS: 2US FAERS
378Deposit eyeFAERS: 2US FAERS
379Dermatitis acneiformFAERS: 2US FAERS
380Device FailureFAERS: 2US FAERS
381Diabetes mellitus inadequate controlFAERS: 2US FAERS
382DysarthriaFAERS: 2US FAERS
383EmbolismFAERS: 2SIDER
US FAERS
384EpiscleritisFAERS: 2US FAERS
385ErythropsiaFAERS: 2US FAERS
386Eye prosthesis userFAERS: 2US FAERS
387Eyelid infectionFAERS: 2US FAERS
388Facial PainFAERS: 2US FAERS
389Foreign body traumaFAERS: 2US FAERS
390Gastric ulcerFAERS: 2US FAERS
391Gastrointestinal carcinomaFAERS: 2US FAERS
392Gastrointestinal infectionFAERS: 2US FAERS
393GingivitisFAERS: 2US FAERS
394HepatitisFAERS: 2OFFSIDES
US FAERS
395Impaired driving abilityFAERS: 2US FAERS
396Incorrect dose administered by deviceFAERS: 2US FAERS
397Intentional dose omissionFAERS: 2US FAERS
398Intentional drug misuseFAERS: 2US FAERS
399Intentional self-injuryFAERS: 2US FAERS
400Joint Range of Motion DecreasedFAERS: 2US FAERS
401KeratoconusFAERS: 2US FAERS
402LacerationFAERS: 2US FAERS
403Lack of spontaneous speechFAERS: 2US FAERS
404LaryngitisFAERS: 2US FAERS
405Larynx irritationFAERS: 2US FAERS
406Lip and/or oral cavity cancerFAERS: 2US FAERS
407Lower respiratory tract infectionFAERS: 2US FAERS
408MYELODYSPLASTIC SYNDROMEFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
409Malignant neoplasm progressionFAERS: 2US FAERS
410Medical device complicationFAERS: 2US FAERS
411MeibomianitisFAERS: 2US FAERS
412MeningitisFAERS: 2US FAERS
413Meniscus injuryFAERS: 2US FAERS
414MonoplegiaFAERS: 2US FAERS
415Myasthenia GravisFAERS: 2US FAERS
416Ocular icterusFAERS: 2US FAERS
417OnychoclasisFAERS: 2US FAERS
418Optic Nerve HypoplasiaFAERS: 2US FAERS
419Oral mucosal exfoliationFAERS: 2US FAERS
420Oropharyngeal blisteringFAERS: 2US FAERS
421OtosclerosisFAERS: 2US FAERS
422Pancreatic NeoplasmFAERS: 2US FAERS
423Periorbital contusionFAERS: 2US FAERS
424Peripheral artery occlusionFAERS: 2US FAERS
425Polymyalgia RheumaticaFAERS: 2OFFSIDES
US FAERS
426PolyuriaFAERS: 2US FAERS
427Poor peripheral circulationFAERS: 2US FAERS
428Poor quality sleepFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
429Post procedural infectionFAERS: 2US FAERS
430Premature EjaculationFAERS: 2US FAERS
431Product closure issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
432Product design issueFAERS: 2US FAERS
433Product leakageFAERS: 2US FAERS
434Product lot number issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
435Product prescribing errorFAERS: 2US FAERS
436PurpuraFAERS: 2US FAERS
437Renal cystFAERS: 2US FAERS
438Renal painFAERS: 2US FAERS
439Respiratory arrestFAERS: 2US FAERS
440RetchingFAERS: 2US FAERS
441Retinal vascular thrombosisFAERS: 2US FAERS
442ScabFAERS: 2SIDER
US FAERS
443Scleral thinningFAERS: 2US FAERS
444ScotomaFAERS: 2OFFSIDES
US FAERS
445ShockFAERS: 2US FAERS
446Sinus headacheFAERS: 2US FAERS
447Sinus painFAERS: 2US FAERS
448Skin lesionFAERS: 2US FAERS
449Skin necrosisFAERS: 2OFFSIDES
US FAERS
450StomatitisFAERS: 2US FAERS
451Suspected counterfeit productFAERS: 2US FAERS
452Tarsal Tunnel SyndromeFAERS: 2OFFSIDES
US FAERS
453Temperature intoleranceFAERS: 2US FAERS
454Tension HeadacheFAERS: 2US FAERS
455Therapy cessationFAERS: 2US FAERS
456Thermal burnFAERS: 2US FAERS
457Thrombotic strokeFAERS: 2US FAERS
458Transaminases increasedFAERS: 2US FAERS
459TrichomegalyFAERS: 2US FAERS
460Vaginal ProlapseFAERS: 2US FAERS
461Walking aid userFAERS: 2US FAERS
462Wheelchair userFAERS: 2US FAERS
463XanthomaFAERS: 2US FAERS
464furuncleFAERS: 2US FAERS
465Achromotrichia acquiredFAERS: 1US FAERS
466Acute Coronary SyndromeFAERS: 1US FAERS
467Acute respiratory failureFAERS: 1US FAERS
468Administration site rashFAERS: 1US FAERS
469Administration site reactionFAERS: 1US FAERS
470Adulterated productFAERS: 1US FAERS
471Alcohol interactionFAERS: 1US FAERS
472Alpha 1 foetoprotein decreasedFAERS: 1US FAERS
473Amniotic fluid volume decreasedFAERS: 1US FAERS
474Amyotrophic Lateral SclerosisFAERS: 1US FAERS
475Analgesic asthma syndromeFAERS: 1US FAERS
476AngioplastyFAERS: 1US FAERS
477Ankylosing spondylitisFAERS: 1US FAERS
478Aortic bypassFAERS: 1US FAERS
479Aortic occlusionFAERS: 1US FAERS
480Apallic syndromeFAERS: 1US FAERS
481Application site swellingFAERS: 1US FAERS
482Atrial tachycardiaFAERS: 1OFFSIDES
US FAERS
483Benign NeoplasmFAERS: 1US FAERS
484BlepharosynechiaFAERS: 1US FAERS
485Blood cholesterolFAERS: 1OFFSIDES
US FAERS
486Blood pressure orthostatic abnormalFAERS: 1US FAERS
487Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
488Blood triglycerides increasedFAERS: 1US FAERS
489Bone contusionFAERS: 1US FAERS
490Bronchial irritationFAERS: 1US FAERS
491BronchopneumoniaFAERS: 1US FAERS
492Cardiac procedure complicationFAERS: 1US FAERS
493Cataract operation complicationFAERS: 1US FAERS
494CellulitisFAERS: 1US FAERS
495Central nervous system lesionFAERS: 1US FAERS
496Cerebral disorderFAERS: 1US FAERS
497ChemotherapyFAERS: 1US FAERS
498Complication associated with deviceFAERS: 1US FAERS
499Compression fractureFAERS: 1US FAERS
500Contraindicated product administeredFAERS: 1US FAERS
501Corneal InfectionFAERS: 1US FAERS
502Corneal exfoliationFAERS: 1US FAERS
503Corneal implantFAERS: 1US FAERS
504Corneal striaeFAERS: 1US FAERS
505Corneal thinningFAERS: 1US FAERS
506Corrective lens userFAERS: 1US FAERS
507CryingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
508Cutis LaxaFAERS: 1US FAERS
509Dacryostenosis acquiredFAERS: 1US FAERS
510Depressed Level of ConsciousnessFAERS: 1US FAERS
511Diabetic FootFAERS: 1US FAERS
512Diabetic metabolic decompensationFAERS: 1US FAERS
513Disease complicationFAERS: 1US FAERS
514DistichiasisFAERS: 1US FAERS
515Drug DependenceFAERS: 1US FAERS
516Drug administered at inappropriate siteFAERS: 1US FAERS
517Drug dispensed to wrong patientFAERS: 1US FAERS
518Dural fistulaFAERS: 1US FAERS
519Economic problemFAERS: 1US FAERS
520EctropionFAERS: 1US FAERS
521Emotional distressFAERS: 1OFFSIDES
US FAERS
522EnophthalmosFAERS: 1US FAERS
523EntropionFAERS: 1US FAERS
524Escherichia infectionFAERS: 1OFFSIDES
US FAERS
525ExophthalmosFAERS: 1US FAERS
526Exposure via direct contactFAERS: 1US FAERS
527Exposure via skin contactFAERS: 1US FAERS
528Eye excisionFAERS: 1US FAERS
529Eyeball avulsionFAERS: 1US FAERS
530Eyelash changesFAERS: 1US FAERS
531Eyelash hyperpigmentationFAERS: 1US FAERS
532Facial NeuralgiaFAERS: 1US FAERS
533Feeling of body temperature changeFAERS: 1US FAERS
534FibromyalgiaFAERS: 1US FAERS
535FlatulenceFAERS: 1US FAERS
536Food PoisoningFAERS: 1US FAERS
537FormicationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
538Frustration tolerance decreasedFAERS: 1US FAERS
539FrustrationFAERS: 1US FAERS
540Gallbladder painFAERS: 1US FAERS
541Gastric infectionFAERS: 1US FAERS
542Gastroenteritis helicobacterFAERS: 1US FAERS
543Gastrointestinal sounds abnormalFAERS: 1US FAERS
544Gastrooesophageal cancerFAERS: 1US FAERS
545General physical condition abnormalFAERS: 1US FAERS
546Genital dischargeFAERS: 1US FAERS
547Glioblastoma MultiformeFAERS: 1US FAERS
548GlioblastomaFAERS: 1US FAERS
549GoutFAERS: 1OFFSIDES
US FAERS
550Granulocyte count increasedFAERS: 1US FAERS
551Granuloma AnnulareFAERS: 1US FAERS
552Groin infectionFAERS: 1US FAERS
553Heat ExhaustionFAERS: 1US FAERS
554HepatomegalyFAERS: 1US FAERS
555Hip surgeryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
556HyperkeratosisFAERS: 1US FAERS
557Hypertensive crisisFAERS: 1US FAERS
558Hypopigmentation of eyelidFAERS: 1US FAERS
559HypopyonFAERS: 1US FAERS
560ImmobileFAERS: 1US FAERS
561Incision site complicationFAERS: 1US FAERS
562Incorrect dose administered by productFAERS: 1US FAERS
563Incorrect drug administration durationFAERS: 1US FAERS
564Incorrect drug administration rateFAERS: 1US FAERS
565Incorrect product administration durationFAERS: 1US FAERS
566Incorrect route of drug administrationFAERS: 1US FAERS
567IndurationFAERS: 1US FAERS
568Instillation site abnormal sensationFAERS: 1US FAERS
569Instillation site complicationFAERS: 1US FAERS
570Instillation site lacrimationFAERS: 1US FAERS
571Instillation site reactionFAERS: 1US FAERS
572Intervertebral Disc DegenerationFAERS: 1US FAERS
573Intestinal resectionFAERS: 1OFFSIDES
US FAERS
574Intestinal ulcer perforationFAERS: 1US FAERS
575Intracranial AneurysmFAERS: 1US FAERS
576Intraocular lens extractionFAERS: 1US FAERS
577Iritic melanomaFAERS: 1US FAERS
578Keratoconjunctivitis SiccaFAERS: 1US FAERS
579KeratopathyFAERS: 1SIDER
US FAERS
580KeratorhexisFAERS: 1OFFSIDES
US FAERS
581Lacrimation decreasedFAERS: 1US FAERS
582Lenticular pigmentationFAERS: 1US FAERS
583Leukocytoclastic vasculitisFAERS: 1US FAERS
584Lid sulcus deepenedFAERS: 1US FAERS
585Ligament ruptureFAERS: 1OFFSIDES
US FAERS
586Limb asymmetryFAERS: 1US FAERS
587Limb operationFAERS: 1US FAERS
588Localised intraabdominal fluid collectionFAERS: 1US FAERS
589Loss of personal independence in daily activitiesFAERS: 1US FAERS
590Low density lipoprotein increasedFAERS: 1US FAERS
591LymphadenopathyFAERS: 1US FAERS
592LymphomaFAERS: 1US FAERS
593Macular fibrosisFAERS: 1US FAERS
594Macular ruptureFAERS: 1US FAERS
595Malignant melanoma of sites other than skinFAERS: 1US FAERS
596Manufacturing product shipping issueFAERS: 1US FAERS
597Maternal exposure during pregnancyFAERS: 1US FAERS
598Medication tamperingFAERS: 1US FAERS
599Meibomian gland dysfunctionFAERS: 1US FAERS
600MelanosisFAERS: 1US FAERS
601Meniscus removalFAERS: 1US FAERS
602Mental RetardationFAERS: 1US FAERS
603Metastatic NeoplasmFAERS: 1US FAERS
604MetrorrhagiaFAERS: 1US FAERS
605Migraine with AuraFAERS: 1US FAERS
606Multiple SclerosisFAERS: 1US FAERS
607Myoglobin blood increasedFAERS: 1US FAERS
608Nasal inflammationFAERS: 1US FAERS
609No reaction on previous exposure to drugFAERS: 1US FAERS
610Non-cardiac chest painFAERS: 1US FAERS
611Nonspecific reactionFAERS: 1US FAERS
612NystagmusFAERS: 1US FAERS
613OnycholysisFAERS: 1US FAERS
614Ophthalmic vein thrombosisFAERS: 1US FAERS
615Optic AtrophyFAERS: 1OFFSIDES
US FAERS
616Oral candidiasisFAERS: 1US FAERS
617Oral painFAERS: 1US FAERS
618PO2 decreasedFAERS: 1US FAERS
619Pain of skinFAERS: 1US FAERS
620PallorFAERS: 1US FAERS
621PancreatitisFAERS: 1US FAERS
622Paradoxical drug reactionFAERS: 1US FAERS
623Paranasal sinus discomfortFAERS: 1US FAERS
624ParaplegiaFAERS: 1US FAERS
625PeritonitisFAERS: 1US FAERS
626Pharmaceutical product counterfeitFAERS: 1US FAERS
627Physical disabilityFAERS: 1US FAERS
628Platelet TransfusionFAERS: 1US FAERS
629PneumothoraxFAERS: 1US FAERS
630Post procedural discomfortFAERS: 1US FAERS
631Postoperative infectionFAERS: 1US FAERS
632Prescription drug used without a prescriptionFAERS: 1US FAERS
633PresyncopeFAERS: 1US FAERS
634Product contamination microbialFAERS: 1US FAERS
635Product distribution issueFAERS: 1US FAERS
636Product expiration date issueFAERS: 1US FAERS
637Product measured potency issueFAERS: 1US FAERS
638Product selection errorFAERS: 1US FAERS
639ProstatectomyFAERS: 1US FAERS
640Prosthesis userFAERS: 1US FAERS
641Pruritus allergicFAERS: 1US FAERS
642Pulmonary arterial hypertensionFAERS: 1US FAERS
643Pulmonary arterial pressure increasedFAERS: 1US FAERS
644Pulmonary congestionFAERS: 1US FAERS
645Pulmonary thrombosisFAERS: 1OFFSIDES
US FAERS
646PyelonephritisFAERS: 1US FAERS
647Rash erythematousFAERS: 1US FAERS
648Reaction to excipientFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
649Renal Artery StenosisFAERS: 1US FAERS
650Renal artery occlusionFAERS: 1US FAERS
651Respiratory distressFAERS: 1US FAERS
652Restless Legs SyndromeFAERS: 1US FAERS
653Retinal cystFAERS: 1US FAERS
654Retinal depigmentationFAERS: 1US FAERS
655Retinitis PigmentosaFAERS: 1US FAERS
656RetinoschisisFAERS: 1US FAERS
657Rheumatic disorderFAERS: 1US FAERS
658Rhinovirus infectionFAERS: 1US FAERS
659SciaticaFAERS: 1US FAERS
660ScreamingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
661Sight disabilityFAERS: 1US FAERS
662Simplex virus test positiveFAERS: 1US FAERS
663Skin UlcerFAERS: 1US FAERS
664Skin WrinklingFAERS: 1US FAERS
665Skin irritationFAERS: 1US FAERS
666Skin reactionFAERS: 1SIDER
US FAERS
667Skin tightnessFAERS: 1US FAERS
668Stent occlusionFAERS: 1US FAERS
669Stevens-Johnson SyndromeFAERS: 125811541CTD
OFFSIDES
US FAERS
670StillbirthFAERS: 1US FAERS
671Suicide attemptFAERS: 1US FAERS
672SunburnFAERS: 1US FAERS
673Swelling of eyelidFAERS: 1US FAERS
674SymblepharonFAERS: 1US FAERS
675Tardive DyskinesiaFAERS: 1US FAERS
676TensionFAERS: 1US FAERS
677Therapeutic product contaminationFAERS: 1US FAERS
678Therapeutic product effect incompleteFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
679Therapeutic response changedFAERS: 1US FAERS
680Therapy non-responderFAERS: 1OFFSIDES
US FAERS
681Tick-borne feverFAERS: 1US FAERS
682Tooth ErosionFAERS: 1US FAERS
683Tooth InfectionFAERS: 1US FAERS
684Toxic anterior segment syndromeFAERS: 1US FAERS
685TrabeculectomyFAERS: 1US FAERS
686TracheitisFAERS: 1US FAERS
687TrichiasisFAERS: 1US FAERS
688TuberculosisFAERS: 1US FAERS
689Upper respiratory tract congestionFAERS: 1US FAERS
690Urinary IncontinenceFAERS: 1US FAERS
691Vaginal DischargeFAERS: 1US FAERS
692Vascular bypass graftFAERS: 1US FAERS
693Vascular occlusionFAERS: 1US FAERS
694VasculitisFAERS: 1US FAERS
695VasospasmFAERS: 1US FAERS
696Vein wall hypertrophyFAERS: 1US FAERS
697Venous occlusionFAERS: 1US FAERS
698Ventricular hypertrophyFAERS: 1US FAERS
699Vertebral lesionFAERS: 1US FAERS
700Vessel perforationFAERS: 1US FAERS
701Violence-related symptomFAERS: 1US FAERS
702Viral upper respiratory tract infectionFAERS: 1US FAERS
703VitiligoFAERS: 1US FAERS
704VitrectomyFAERS: 1US FAERS
705Vulvovaginal discomfortFAERS: 1US FAERS
706White blood cell count decreasedFAERS: 1US FAERS
707Wrong product administeredFAERS: 1US FAERS
708Wrong technique in device usage processFAERS: 1US FAERS
709muscle injuryFAERS: 1US FAERS
710ovarian neoplasmFAERS: 1US FAERS
711Abdominal tendernessOFFSIDES
712Abnormal visionOFFSIDES
713Acute glomerulonephritisOFFSIDES
714Acute myocardial infarctionOFFSIDES
715Acute prerenal failureOFFSIDES
716AdenocarcinomaOFFSIDES
717Allergic skin reactionSIDER
718AlveolitisOFFSIDES
719Anticonvulsant drug level increasedOFFSIDES
720Application site drynessCanada Vigilance: 1Canada Vigilance
721Application site erythemaCanada Vigilance: 2Canada Vigilance
722Application site hypersensitivityCanada Vigilance: 1Canada Vigilance
723Aspartate aminotransferase decreasedOFFSIDES
724AtelectasisOFFSIDES
725AtherosclerosisOFFSIDES
726Atrial thrombosisOFFSIDES
727AuraOFFSIDES
728Blood GlucoseOFFSIDES
729Blood beta-D-glucan increasedOFFSIDES
730Blood fibrinogen increasedOFFSIDES
731Blood lactate dehydrogenase decreasedOFFSIDES
732Blood potassium increasedOFFSIDES
733Blood potassiumOFFSIDES
734Blood sodium increasedOFFSIDES
735Blood sodiumOFFSIDES
736Blurred visionOFFSIDES
737Body TemperatureOFFSIDES
738Bone lesionOFFSIDES
739Brain natriuretic peptide increasedOFFSIDES
740Brain scan abnormalOFFSIDES
741CalcinosisOFFSIDES
742Cardiac TamponadeOFFSIDES
743Carotid bruitOFFSIDES
744Catheter placementOFFSIDES
745Cerebral artery stenosisOFFSIDES
746Cholecystitis infectiveOFFSIDES
747Chronic Fatigue SyndromeOFFSIDES
748Clostridium difficile toxin test positiveOFFSIDES
749ConfabulationOFFSIDES
750Conjunctival depositOFFSIDES
751Dental abscessOFFSIDES
752DermatomyositisOFFSIDES
753Diabetes InsipidusOFFSIDES
754Disseminated Intravascular CoagulationOFFSIDES
755DiverticulumOFFSIDES
756Drug addictOFFSIDES
757DuodenitisOFFSIDES
758EmbolusSIDER
759EmpyemaOFFSIDES
760EndophthalmitisOFFSIDES
761Exacerbation of asthmaSIDER
762Exfoliation Syndrome15002024CTD
763Extremity necrosisOFFSIDES
764Eyelid DiseasesOFFSIDES
765Fear of fallingOFFSIDES
766Fluid overloadOFFSIDES
767GamblingOFFSIDES
768Glaucoma, Open-Angle

View details

CTD
769GranulocytosisOFFSIDES
770Hallucinations, mixedOFFSIDES
771Hungry bone syndromeOFFSIDES
772Hyperemia

View details

CTD
773HyperparathyroidismOFFSIDES
774HypoxiaOFFSIDES
775HysterectomyOFFSIDES
776IleitisOFFSIDES
777Intervertebral disc disorderOFFSIDES
778Intestinal PerforationOFFSIDES
779Kidney FailureOFFSIDES
780LaryngospasmOFFSIDES
781Left atrial dilatationOFFSIDES
782LeukoencephalopathyOFFSIDES
783Ligament injuryOFFSIDES
784Localised skin reactionSIDER
785Lupus pneumonitisOFFSIDES
786Mental status changesOFFSIDES
787Metabolic acidosisOFFSIDES
788Nephrogenic Fibrosing DermopathyOFFSIDES
789Occult blood positiveOFFSIDES
790Optic Disc EdemaOFFSIDES
791Optic NeuropathyOFFSIDES
792OsteolysisOFFSIDES
793OsteomyelitisOFFSIDES
794OsteopeniaOFFSIDES
795PanophthalmitisOFFSIDES
796PapuleCanada Vigilance: 1Canada Vigilance
797ParanoiaOFFSIDES
798ParophthalmiaOFFSIDES
799PeriarthritisOFFSIDES
800Pericarditis lupusOFFSIDES
801PericarditisOFFSIDES
802PhlebitisOFFSIDES
803PlasmapheresisOFFSIDES
804Prescribed overdoseCanada Vigilance: 1Canada Vigilance
805Progesterone receptor assayOFFSIDES
806Pseudomonal sepsisOFFSIDES
807QuadriparesisOFFSIDES
808RalesOFFSIDES
809Red blood cell schistocytes presentOFFSIDES
810Renal tubular necrosisOFFSIDES
811SarcoidosisOFFSIDES
812Septic ShockOFFSIDES
813Shoulder PainOFFSIDES
814SoporOFFSIDES
815Spinal column stenosisOFFSIDES
816SpondylolysisOFFSIDES
817Superficial ThrombophlebitisOFFSIDES
818Superior Vena Cava SyndromeOFFSIDES
819Synovial CystOFFSIDES
820Therapeutic product effect delayedCanada Vigilance: 1Canada Vigilance
821Toxic Epidermal NecrolysisSIDER
822Urinary tract infection fungalOFFSIDES
823Urine flow decreasedOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.